MA49148A - Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation - Google Patents

Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Info

Publication number
MA49148A
MA49148A MA049148A MA49148A MA49148A MA 49148 A MA49148 A MA 49148A MA 049148 A MA049148 A MA 049148A MA 49148 A MA49148 A MA 49148A MA 49148 A MA49148 A MA 49148A
Authority
MA
Morocco
Prior art keywords
dgla
acid
pharmaceutical compositions
compositions consisting
pharmaceutical
Prior art date
Application number
MA049148A
Other languages
English (en)
Inventor
John Climax
David Coughlan
Mehar Manku
Original Assignee
Ds Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ds Biopharma Ltd filed Critical Ds Biopharma Ltd
Publication of MA49148A publication Critical patent/MA49148A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA049148A 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation MA49148A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762508818P 2017-05-19 2017-05-19

Publications (1)

Publication Number Publication Date
MA49148A true MA49148A (fr) 2020-03-25

Family

ID=62791771

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049148A MA49148A (fr) 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Country Status (6)

Country Link
US (1) US20180333382A1 (fr)
EP (1) EP3624787A1 (fr)
JP (1) JP2020520938A (fr)
CN (1) CN110996937A (fr)
MA (1) MA49148A (fr)
WO (1) WO2018211325A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7743289B2 (ja) * 2020-11-30 2025-09-24 花王株式会社 アトピー性皮膚炎の症度の検出方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5546087B2 (ja) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
CA2599112C (fr) * 2005-02-14 2013-10-22 Suntory Limited Composition comprenant l'acide dihomo-.gamma.-linolenique (adgl) comme matiere active
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
MX375328B (es) * 2014-06-04 2025-03-06 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
CN108778266A (zh) * 2016-01-07 2018-11-09 Ds生物制药有限公司 包含二高γ亚麻酸(DGLA)的医药组合物和其用途

Also Published As

Publication number Publication date
EP3624787A1 (fr) 2020-03-25
JP2020520938A (ja) 2020-07-16
CN110996937A (zh) 2020-04-10
WO2018211325A1 (fr) 2018-11-22
US20180333382A1 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
EP3630145A4 (fr) Compositions pharmaceutiques comprenant du cannabidiol et du bêta-caryophyllène et leurs procédés d'utilisation
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA52257A (fr) Compositions pharmaceutiques comprenant blautia et leur administration orale
EP3548000A4 (fr) Compositions pharmaceutiques d'atropine
EP3715448A4 (fr) Nouvelles bactéries d'acide lactique et leur utilisation
EP3717636A4 (fr) Variants de capsides de virus adéno-associé et leurs procédés d'utilisation
EP3618871A4 (fr) Formulations d'anticorps anti-lag3 etco-formulations d'anticorps anti-lag3 et d'anticorps anti-pd-1
EP3880688A4 (fr) Préparations et compositions d'oligosaccharides
EP3518971A4 (fr) Formulations thérapeutiques d'anticorps et de protéines et leurs utilisations
EP3310343A4 (fr) Compositions implantables pour administration de médicaments et méthodes d'utilisation desdites compositions
MA46044A (fr) Compositions de nettoyage comprenant un acide aminé et leurs procédés d'utilisation
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
MA48461A (fr) Excipients pour réduire la viscosité de formulations d'anticorps et compositions de formulation
EP3334719A4 (fr) Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques
EP3897593A4 (fr) Formulations de cannabinoïdes et compositions pharmaceutiques
MA43361A (fr) Composition pour le soin et la protection de cultures
MA55015A (fr) Formulations pharmaceutiques
MA41326A (fr) Formulations pharmaceutiques comprenant du cangrelor de haute pureté et leurs procédés de préparation et d'utilisation
EP3452441A4 (fr) Dérivés d'acide alpha-truxillique et compositions pharmaceutiques associées
EP3373907A4 (fr) Compositions pharmaceutiques à libération prolongée et méthodes d'utilisation
MA46436A (fr) Compositions comprenant de la relaxine et leurs méthodes d'utilisation
EP4031520A4 (fr) Compositions d'imagerie et thérapeutiques
EP3946277A4 (fr) Compositions pharmaceutiques orodispersibles d'apixaban
EP3664797A4 (fr) Ligands de nr4a1, compositions pharmaceutiques et procédés d'utilisation associés